Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1607195

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1607195

Glucuronolactone Market by End-Use (Food & Beverages, Pharmaceuticals), Application (Additives, Antioxidants, Energy Supplements) - Global Forecast 2025-2030

PUBLISHED:
PAGES: 185 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Glucuronolactone Market was valued at USD 401.22 million in 2023, expected to reach USD 418.99 million in 2024, and is projected to grow at a CAGR of 5.87%, to USD 598.43 million by 2030.

Glucuronolactone is a naturally occurring chemical compound, often included in energy drinks and dietary supplements due to its reputed detoxification properties and ability to improve cognitive function and physical performance. As a market research analyst at 360iResearch focusing on this compound, the scope encompasses its necessity derived from its use as an effective supplement to enhance vitality and mental acuity. Its application extends across industries, primarily utilized in food and beverages, pharmaceuticals, and the nutraceutical sector, where it's celebrated for potential health benefits, including liver support and reduced muscle fatigue post-exercise. The end-use scope is broad, covering consumer health, sports nutrition, and possibly expanding into pharmaceutical formulation as scientific understanding improves.

KEY MARKET STATISTICS
Base Year [2023] USD 401.22 million
Estimated Year [2024] USD 418.99 million
Forecast Year [2030] USD 598.43 million
CAGR (%) 5.87%

Market insights reveal several key growth factors driving glucuronolactone's demand, including rising health consciousness, the expansion of the wellness industry, and increasing consumption of energy-boosting products. Potential opportunities lie in innovating new product formulations that combine glucuronolactone with other functional ingredients, thereby capitalizing on trends favoring personalized nutrition solutions. Recommendations for seizing these opportunities involve investing in R&D for novel delivery systems and formulations, tapping into burgeoning markets in developing countries, and engaging in strategic partnerships that enhance distribution networks.

Nonetheless, the market faces limitations and challenges, such as regulatory scrutiny regarding safety assessments, varying international standards for nutraceutical products, and scientific debates over the compound's efficacy at improving health or performance. Innovation and research could focus on clinical trials to substantiate health claims, development of bioavailable glucuronolactone derivatives, and eco-friendly production processes that enhance sustainability. The nature of the market is dynamic and competitive, with a strong potential for growth if products can safely and effectively meet consumer demands for healthier lifestyles. Strategic positioning, robust consumer education, and compliance with evolving regulatory landscapes are crucial for sustainable business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glucuronolactone Market

The Glucuronolactone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption of energy drinks all over the world
    • Increasing consumptions to enhance physical performance
    • Surging automotive and industrial applications
  • Market Restraints
    • Concern regarding side effects of glucuronolactone
  • Market Opportunities
    • Rapid adoption of nutritional supplements
    • Emerging usage in pharmaceutical sector
  • Market Challenges
    • Lack of scientific proof for glucuronolactone efficacy

Porter's Five Forces: A Strategic Tool for Navigating the Glucuronolactone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glucuronolactone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glucuronolactone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glucuronolactone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glucuronolactone Market

A detailed market share analysis in the Glucuronolactone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glucuronolactone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glucuronolactone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glucuronolactone Market

A strategic analysis of the Glucuronolactone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucuronolactone Market, highlighting leading vendors and their innovative profiles. These include Aceto Corporation, Anhui Fubore Pharmaceutical and Chemical Co., Ltd., Anmol Chemicals Industries Private Limited, Biosynth Ltd., Creative Compounds LLC, Fengchen Group Co. Ltd., Foodchem International Corporation, Jungbunzlauer Suisse AG, Merck KGaA, Newseed Chemical Co., Limited, PepsiCo, Inc., Red Bull GmbH, and Roquette Freres S.A..

Market Segmentation & Coverage

This research report categorizes the Glucuronolactone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on End-Use, market is studied across Food & Beverages and Pharmaceuticals.
  • Based on Application, market is studied across Additives, Antioxidants, Energy Supplements, Preservatives, and Processing Aids.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-742BD517F39A

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption of energy drinks all over the world
      • 5.1.1.2. Increasing consumptions to enhance physical performance
      • 5.1.1.3. Surging automotive and industrial applications
    • 5.1.2. Restraints
      • 5.1.2.1. Concern regarding side effects of glucuronolactone
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid adoption of nutritional supplements
      • 5.1.3.2. Emerging usage in pharmaceutical sector
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of scientific proof for glucuronolactone efficacy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glucuronolactone Market, by End-Use

  • 6.1. Introduction
  • 6.2. Food & Beverages
  • 6.3. Pharmaceuticals

7. Glucuronolactone Market, by Application

  • 7.1. Introduction
  • 7.2. Additives
  • 7.3. Antioxidants
  • 7.4. Energy Supplements
  • 7.5. Preservatives
  • 7.6. Processing Aids

8. Americas Glucuronolactone Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Glucuronolactone Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Glucuronolactone Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aceto Corporation
  • 2. Anhui Fubore Pharmaceutical and Chemical Co., Ltd.
  • 3. Anmol Chemicals Industries Private Limited
  • 4. Biosynth Ltd.
  • 5. Creative Compounds LLC
  • 6. Fengchen Group Co. Ltd.
  • 7. Foodchem International Corporation
  • 8. Jungbunzlauer Suisse AG
  • 9. Merck KGaA
  • 10. Newseed Chemical Co., Limited
  • 11. PepsiCo, Inc.
  • 12. Red Bull GmbH
  • 13. Roquette Freres S.A.
Product Code: MRR-742BD517F39A

LIST OF FIGURES

  • FIGURE 1. GLUCURONOLACTONE MARKET RESEARCH PROCESS
  • FIGURE 2. GLUCURONOLACTONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLUCURONOLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLUCURONOLACTONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. GLUCURONOLACTONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLUCURONOLACTONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLUCURONOLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLUCURONOLACTONE MARKET DYNAMICS
  • TABLE 7. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY ANTIOXIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY ENERGY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY PROCESSING AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GLUCURONOLACTONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. GLUCURONOLACTONE MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!